Karl Hecker, Tony Galindo, Agilent, Thermo Electron, BD, GeneOhm, Proteomics Research, Beckman, Expression Pathology, Ciphergen | GenomeWeb

People

Karl Hecker has joined PerkinElmer as director of research and development for its Boston-based center of excellence, the firm said this week. Hecker joins PerkinElmer from Invitrogen.

He will be responsible for leading all product R&D efforts for molecular medicine within the company's life and analytical sciences unit. Hecker holds a PhD in biochemistry from Florida State University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.